KB02-JQ1 is a cutting-edge molecular glue designed to facilitate targeted protein degradation, specifically aimed at the bromodomain and extra-terminal (BET) family proteins, with a primary binding site on BRD4. This small molecule exhibits high specificity and affinity, functioning by recruiting the E3 ubiquitin ligase complex to the BET proteins, thereby promoting their ubiquitination and subsequent proteasomal degradation. The molecular characteristics of KB02-JQ1 include a unique structure that enhances its interaction with both the target protein and the ubiquitin-proteasome system, ensuring efficient degradation. In research applications, KB02-JQ1 serves as a pivotal tool in the study of transcriptional regulation and epigenetic control, offering insights into the modulation of gene expression. Its utility extends to exploring the therapeutic potential of targeting BET proteins in various pathological conditions, making it invaluable for scientists focused on advancing the field of targeted protein degradation. The application of KB02-JQ1 in experimental settings provides a robust platform for unraveling complex biological processes and developing innovative therapeutic strategies.
Structure of 2384184-44-3
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
E3 Ligase: KB02-JQ1 functions by recruiting the cereblon (CRBN) E3 ligase, facilitating the ubiquitination of its target proteins. This interaction leverages CRBN's substrate recognition domain to bring the target into proximity for efficient degradation.
Target Protein: The primary target of KB02-JQ1 is BRD4, a member of the BET family of bromodomain-containing proteins involved in transcriptional regulation. By engaging BRD4, KB02-JQ1 effectively modulates chromatin dynamics and transcriptional programs in cells.
Degradation Mechanism: KB02-JQ1 induces proteasomal degradation of BRD4 through the ubiquitin–proteasome system. The molecular glue stabilizes the ternary complex between CRBN and BRD4, promoting polyubiquitination and subsequent recognition by the 26S proteasome, leading to targeted protein clearance.
Applications• Molecular Glue in Protein Interaction Modulation: KB02-JQ1 serves as a potent molecular glue, facilitating the stabilization of protein-protein interactions. This aids researchers in studying the dynamic interplay between proteins, providing insights into cellular processes and potential therapeutic targets.
• Targeted Degradation in Cancer Research: By promoting the degradation of oncogenic proteins, KB02-JQ1 enables targeted protein degradation studies. Researchers can explore its role in disrupting cancer cell proliferation, offering a pathway to novel anti-cancer strategies.
• Enhancing Proteolysis for Drug Discovery: KB02-JQ1's ability to induce selective proteolysis makes it a valuable tool in drug discovery. It helps identify and validate new drug targets by facilitating the degradation of disease-relevant proteins, streamlining the development of innovative treatments.
• Advancing Molecular Glue Mechanism Studies: KB02-JQ1 is instrumental in elucidating the mechanisms of molecular glue action. Researchers can investigate its binding properties and degradation pathways, contributing to a deeper understanding of its role in targeted protein degradation.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.